When I first read that, I was skeptical, EVS as a software company buy a physical products and service company seems odd. However, I think you are on to something - there seems to be a cross selling opportunity there (in my very lay opinion). The kind of thing a larger more established company would do, i.e. find what else there customers want and then acquire a company that offers that, as it is sometimes easier to get a new product than new customers.
I mean, I think it is unlikely and would be a distraction at this point, but could be a good fit if the growth being promised elsewhere is slower than managers and shareholders would like.
All IMO, please DYOR and GLTAH.
- Forums
- ASX - By Stock
- EVS
- Ann: Envirosuite Reports Q2 FY2021 Sales Update
Ann: Envirosuite Reports Q2 FY2021 Sales Update, page-54
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add EVS (ASX) to my watchlist
(20min delay)
|
|||||
Last
5.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $69.75M |
Open | High | Low | Value | Volume |
5.5¢ | 5.5¢ | 5.5¢ | $3.308K | 60.14K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 19 | 5.6¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
5.7¢ | 205947 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 4881 | 0.056 |
1 | 198575 | 0.055 |
2 | 75063 | 0.054 |
1 | 461749 | 0.053 |
4 | 171632 | 0.052 |
Price($) | Vol. | No. |
---|---|---|
0.055 | 5500 | 1 |
0.057 | 205947 | 2 |
0.058 | 50000 | 1 |
0.059 | 52500 | 2 |
0.060 | 105481 | 3 |
Last trade - 14.27pm 15/07/2024 (20 minute delay) ? |
Featured News
EVS (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online